Biotage AB
STO:BIOT

Watchlist Manager
Biotage AB Logo
Biotage AB
STO:BIOT
Watchlist
Price: 160.8 SEK -1.65% Market Closed
Market Cap: 12.8B SEK
Have any thoughts about
Biotage AB?
Write Note

Biotage AB
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biotage AB
Cash from Financing Activities Peer Comparison

Comparables:
ALIF B
BICO
G
GENO
MCAP
M
MAGLE

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
Biotage AB
STO:BIOT
Cash from Financing Activities
-kr154m
CAGR 3-Years
13%
CAGR 5-Years
-7%
CAGR 10-Years
-12%
AddLife AB
STO:ALIF B
Cash from Financing Activities
-kr554m
CAGR 3-Years
-14%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
BICO Group AB
STO:BICO
Cash from Financing Activities
-kr102m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
G
Genovis AB
STO:GENO
Cash from Financing Activities
-kr5.8m
CAGR 3-Years
1%
CAGR 5-Years
-30%
CAGR 10-Years
N/A
MedCap AB (publ)
STO:MCAP
Cash from Financing Activities
-kr89.5m
CAGR 3-Years
-7%
CAGR 5-Years
-9%
CAGR 10-Years
N/A
M
Magle Chemoswed Holding AB
STO:MAGLE
Cash from Financing Activities
kr2.5m
CAGR 3-Years
-52%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Biotage AB's Cash from Financing Activities?
Cash from Financing Activities
-154m SEK

Based on the financial report for Sep 30, 2024, Biotage AB's Cash from Financing Activities amounts to -154m SEK.

What is Biotage AB's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
-12%

Over the last year, the Cash from Financing Activities growth was -10%. The average annual Cash from Financing Activities growth rates for Biotage AB have been 13% over the past three years , -7% over the past five years , and -12% over the past ten years .

Back to Top